The predicting factors in this model included N2–3 disease, low serum albumin, thrombocytosis, and high pretreatment level of Epstein–Barr virus deoxyribonucleic acid (EBV‐DNA) 42. The gene discussed is ALB; the disease is thrombocytosis disease.